Print
Category: Health News

Washington, DC - The Centers for Disease Control and Prevention (CDC) today announced awards of nearly $110 million to help states and communities strengthen their capacity to track and respond to infectious diseases. The awards represent an increase of about $13 million over fiscal year 2014 funding, with increases going to vaccine-preventable-disease surveillance, foodborne-disease prevention and advanced molecular detection, among other projects.

The funding is allocated through the Epidemiology and Laboratory Capacity for Infectious Diseases Cooperative Agreement (ELC), with a goal of helping states fight infectious disease outbreaks more quickly and develop better interventions to protect the public’s health. Of the nearly $110 million, $51 million is provided through the Affordable Care Act’s Prevention and Public Health Fund. That funding will support:

Expanded funding for state, local, and territorial health departments

“In the last year alone, states were hit with emerging diseases, like chikungunya and respiratory infections from enterovirus D-68, while also responding to outbreaks of measles, foodborne illness, and other threats. These awards lay the foundation for those on the front lines – state and local health departments – to act quickly to prevent illness and deaths,” said Beth P. Bell, M.D., MPH, director of CDC’s National Center for Emerging and Zoonotic Infectious Diseases.

CDC funds all 50 state health departments, six local health departments (Chicago, the District of Columbia, Houston, Los Angeles County, New York City and Philadelphia), and eight territories or U.S. affiliates, including U.S. Virgin Islands, Puerto Rico and Guam, through the ELC mechanism. The funding helps pay the salaries of nearly 1,500 epidemiologists, lab technicians, and health information systems staff in the state, territorial, local, and tribal health departments.

This year’s funding includes:

Funding through the ELC mechanism also supports the nation’s fight against healthcare-associated infections and the growing threat of antibiotic resistance, efforts in which multiple federal agencies and private-sector organizations are participating.